Kraig Biocraft Laboratories, Inc.
KBLB
$0.0798
-$0.0002-0.25%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 785.50K | 397.00K | 673.30K | 1.19M | 1.52M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 6.90K | 6.90K | 6.90K | 6.90K | 6.90K |
Prepaid Expenses | 46.60K | 48.80K | 60.10K | 41.20K | 5.40K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 839.00K | 452.70K | 740.30K | 1.24M | 1.53M |
|
|||||
Total Current Assets | 839.00K | 452.70K | 740.30K | 1.24M | 1.53M |
Net Property, Plant & Equipment | 95.40K | 111.60K | 130.80K | 145.20K | 125.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.20K | 7.20K | 7.20K | 7.20K | 3.50K |
Total Assets | 1.59M | 1.32M | 1.51M | 2.03M | 2.22M |
|
|||||
Total Accounts Payable | 526.50K | 827.80K | 798.20K | 514.40K | 516.20K |
Total Accrued Expenses | 7.86M | 7.35M | 7.15M | 7.15M | 3.26M |
Short-term Debt | 1.62M | 1.62M | 1.62M | 1.62M | 1.62M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 24.30K | 35.50K | 46.90K | 57.50K | 57.50K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 3.69M |
Total Other Current Liabilities | -- | -- | -- | -- | 3.69M |
Total Current Liabilities | 10.03M | 9.83M | 9.61M | 9.34M | 9.15M |
|
|||||
Total Current Liabilities | 10.03M | 9.83M | 9.61M | 9.34M | 9.15M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 1.62M | 1.62M | 1.62M | 1.62M | 1.62M |
Capital Leases | 34.50K | 37.70K | 40.50K | 42.50K | 45.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 10.06M | 9.86M | 9.66M | 9.38M | 9.19M |
|
|||||
Common Stock & APIC | 40.68M | 39.88M | 39.68M | 39.62M | 39.59M |
Retained Earnings | -54.41M | -53.69M | -53.09M | -52.23M | -51.80M |
Treasury Stock & Other | 22.00K | 22.00K | 22.00K | 22.00K | -- |
Total Common Equity | -13.71M | -13.79M | -13.39M | -12.59M | -12.21M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
|
|||||
Total Common Equity | -13.71M | -13.79M | -13.39M | -12.59M | -12.21M |
Total Preferred Equity | 5.24M | 5.24M | 5.24M | 5.24M | 5.24M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -8.47M | -8.55M | -8.15M | -7.36M | -6.97M |
|